Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncorus, Inc. | Director | Stock Option (right to buy) | 25K | Jun 22, 2022 | Direct | ||
Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Common Stock | 0 | $38.25 | Dec 28, 2021 | Direct | |
Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Restricted Stock Units | 0 | Dec 28, 2021 | Direct | ||
Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Employee Stock Option (Right to Buy) | 0 | Dec 28, 2021 | By Trust | ||
Dicerna Pharmaceuticals Inc | Chief Executive Officer, Director | Employee Stock Option (Right to Buy) | 0 | Dec 28, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONCR | Oncorus, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
ONCR | Oncorus, Inc. | Jun 22, 2022 | 0 | $0 | 3 | Jun 24, 2022 | Director |
DRNA | Dicerna Pharmaceuticals Inc | Dec 28, 2021 | 15 | -$8.85M | 4 | Dec 29, 2021 | Chief Executive Officer, Director |
DRNA | Dicerna Pharmaceuticals Inc | Dec 15, 2021 | 3 | -$203K | 4 | Dec 17, 2021 | Chief Executive Officer, Director |
DRNA | Dicerna Pharmaceuticals Inc | Dec 10, 2021 | 4 | $600K | 4 | Dec 13, 2021 | Chief Executive Officer, Director |
DRNA | Dicerna Pharmaceuticals Inc | Aug 10, 2021 | 1 | $110K | 4 | Aug 10, 2021 | President and CEO, Director |